Tarr Mark J 4

What Happened
Mark J. Tarr, President & CEO and a director of Encompass Health Corp (EHC), received a total of 113,742 shares of restricted stock in two award issuances. On 2026-02-18 he was issued 100,946 shares (acquired at $0.00) upon satisfaction of performance criteria from a performance share unit award dated Feb 23, 2023. On 2026-02-19 he received an additional 12,796 shares (acquired at $0.00) as an annual restricted stock award under the company’s 2025 Omnibus Performance Incentive Plan. The Form 4 reports the acquisitions as awards/grants (code A) with acquisition price $0.00.

Key Details

• Transaction dates and price: 2026-02-18 — 100,946 shares @ $0.00; 2026-02-19 — 12,796 shares @ $0.00.
• Total shares received: 113,742 restricted shares.
• Shares owned after transaction: Not specified in the filing.
• Footnotes: F1 — issuance from satisfaction of PSU performance criteria (award dated 2/23/2023). F2 — annual restricted stock award under the 2025 Omnibus Performance Incentive Plan.
• Filing date/timeliness: Form 4 filed 2026-02-20 for transactions on 2/18 and 2/19 (filed within the typical Section 16 reporting window).

Context
These were awards of restricted stock (not open-market purchases or sales). The 100,946-share issuance reflects performance-based vesting of a prior PSU award; the 12,796-share award is an annual incentive grant. Such awards represent compensation vesting rather than a direct market buy or sell and do not, by themselves, indicate the insider actively trading stock.